These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 17548515)

  • 1. Contact-dependent inhibition of EGFR signaling by Nf2/Merlin.
    Curto M; Cole BK; Lallemand D; Liu CH; McClatchey AI
    J Cell Biol; 2007 Jun; 177(5):893-903. PubMed ID: 17548515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Merlin regulates transmembrane receptor accumulation and signaling at the plasma membrane in primary mouse Schwann cells and in human schwannomas.
    Lallemand D; Manent J; Couvelard A; Watilliaux A; Siena M; Chareyre F; Lampin A; Niwa-Kawakita M; Kalamarides M; Giovannini M
    Oncogene; 2009 Feb; 28(6):854-65. PubMed ID: 19029950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Membrane organization and tumorigenesis--the NF2 tumor suppressor, Merlin.
    McClatchey AI; Giovannini M
    Genes Dev; 2005 Oct; 19(19):2265-77. PubMed ID: 16204178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of the NF2 gene inhibits schwannoma cell proliferation through promoting PDGFR degradation.
    Fraenzer JT; Pan H; Minimo L; Smith GM; Knauer D; Hung G
    Int J Oncol; 2003 Dec; 23(6):1493-500. PubMed ID: 14612918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidermal growth factor receptor regulates osteoclast differentiation and survival through cross-talking with RANK signaling.
    Yi T; Lee HL; Cha JH; Ko SI; Kim HJ; Shin HI; Woo KM; Ryoo HM; Kim GS; Baek JH
    J Cell Physiol; 2008 Nov; 217(2):409-22. PubMed ID: 18543257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NF2/Merlin mediates contact-dependent inhibition of EGFR mobility and internalization via cortical actomyosin.
    Chiasson-MacKenzie C; Morris ZS; Baca Q; Morris B; Coker JK; Mirchev R; Jensen AE; Carey T; Stott SL; Golan DE; McClatchey AI
    J Cell Biol; 2015 Oct; 211(2):391-405. PubMed ID: 26483553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular transformation by a FERM domain mutant of the Nf2 tumor suppressor gene.
    Johnson KC; Kissil JL; Fry JL; Jacks T
    Oncogene; 2002 Sep; 21(39):5990-7. PubMed ID: 12203111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Shedding light on Merlin's wizardry.
    Okada T; You L; Giancotti FG
    Trends Cell Biol; 2007 May; 17(5):222-9. PubMed ID: 17442573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Re-expression of the tumor suppressor NF2/merlin inhibits invasiveness in mesothelioma cells and negatively regulates FAK.
    Poulikakos PI; Xiao GH; Gallagher R; Jablonski S; Jhanwar SC; Testa JR
    Oncogene; 2006 Sep; 25(44):5960-8. PubMed ID: 16652148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NF2 deficiency promotes tumorigenesis and metastasis by destabilizing adherens junctions.
    Lallemand D; Curto M; Saotome I; Giovannini M; McClatchey AI
    Genes Dev; 2003 May; 17(9):1090-100. PubMed ID: 12695331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of chicken Nf2/merlin indicates regulatory roles in cell proliferation and migration.
    Chen Y; Gutmann DH; Haipek CA; Martinsen BJ; Bronner-Fraser M; Krull CE
    Dev Dyn; 2004 Mar; 229(3):541-54. PubMed ID: 14991710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inactivation of the NF2 tumor suppressor protein merlin in DU145 prostate cancer cells.
    Horiguchi A; Zheng R; Shen R; Nanus DM
    Prostate; 2008 Jun; 68(9):975-84. PubMed ID: 18361411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurofibromatosis type 2/Merlin: sharpening the myth of prometheus.
    Drvarov O; Cubero FJ
    Hepatology; 2011 May; 53(5):1767-70. PubMed ID: 21520182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the NF2 protein merlin and the ERM protein ezrin in human, rat, and mouse central nervous system.
    Grönholm M; Teesalu T; Tyynelä J; Piltti K; Böhling T; Wartiovaara K; Vaheri A; Carpén O
    Mol Cell Neurosci; 2005 Apr; 28(4):683-93. PubMed ID: 15797715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HRS inhibits EGF receptor signaling in the RT4 rat schwannoma cell line.
    Scoles DR; Qin Y; Nguyen V; Gutmann DH; Pulst SM
    Biochem Biophys Res Commun; 2005 Sep; 335(2):385-92. PubMed ID: 16083858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The merlin tumor suppressor interacts with Ral guanine nucleotide dissociation stimulator and inhibits its activity.
    Ryu CH; Kim SW; Lee KH; Lee JY; Kim H; Lee WK; Choi BH; Lim Y; Kim YH; Lee KH; Hwang TK; Jun TY; Rha HK
    Oncogene; 2005 Aug; 24(34):5355-64. PubMed ID: 16007223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of epidermal growth factor receptor signaling by protein kinase C-alpha activation requires CD82, caveolin-1, and ganglioside.
    Wang XQ; Yan Q; Sun P; Liu JW; Go L; McDaniel SM; Paller AS
    Cancer Res; 2007 Oct; 67(20):9986-95. PubMed ID: 17942932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The tumor suppressor merlin interacts with microtubules and modulates Schwann cell microtubule cytoskeleton.
    Muranen T; Grönholm M; Lampin A; Lallemand D; Zhao F; Giovannini M; Carpén O
    Hum Mol Genet; 2007 Jul; 16(14):1742-51. PubMed ID: 17566081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NF2: the wizardry of merlin.
    Xiao GH; Chernoff J; Testa JR
    Genes Chromosomes Cancer; 2003 Dec; 38(4):389-99. PubMed ID: 14566860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurofibromatosis 2 tumor suppressor, the gene induced by valproic acid, mediates neurite outgrowth through interaction with paxillin.
    Yamauchi J; Miyamoto Y; Kusakawa S; Torii T; Mizutani R; Sanbe A; Nakajima H; Kiyokawa N; Tanoue A
    Exp Cell Res; 2008 Jul; 314(11-12):2279-88. PubMed ID: 18486129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.